Literature DB >> 24747214

Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence.

Zhuo A Wang1, Cara L Griffith1, Michael L Skowyra1, Nichole Salinas1, Matthew Williams1, Ezekiel J Maier2, Stacey R Gish1, Hong Liu1, Michael R Brent3, Tamara L Doering4.   

Abstract

Cryptococcus neoformans is an opportunistic yeast responsible for lethal meningoencephalitis in humans. This pathogen elaborates a polysaccharide capsule, which is its major virulence factor. Mannose constitutes over one-half of the capsule mass and is also extensively utilized in cell wall synthesis and in glycosylation of proteins and lipids. The activated mannose donor for most biosynthetic reactions, GDP-mannose, is made in the cytosol, although it is primarily consumed in secretory organelles. This compartmentalization necessitates specific transmembrane transporters to make the donor available for glycan synthesis. We previously identified two cryptococcal GDP-mannose transporters, Gmt1 and Gmt2. Biochemical studies of each protein expressed in Saccharomyces cerevisiae showed that both are functional, with similar kinetics and substrate specificities in vitro. We have now examined these proteins in vivo and demonstrate that cells lacking Gmt1 show significant phenotypic differences from those lacking Gmt2 in terms of growth, colony morphology, protein glycosylation, and capsule phenotypes. Some of these observations may be explained by differential expression of the two genes, but others suggest that the two proteins play overlapping but nonidentical roles in cryptococcal biology. Furthermore, gmt1 gmt2 double mutant cells, which are unexpectedly viable, exhibit severe defects in capsule synthesis and protein glycosylation and are avirulent in mouse models of cryptococcosis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24747214      PMCID: PMC4054277          DOI: 10.1128/EC.00054-14

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  61 in total

1.  Identification and characterization of GONST1, a golgi-localized GDP-mannose transporter in Arabidopsis.

Authors:  T C Baldwin; M G Handford; M I Yuseff; A Orellana; P Dupree
Journal:  Plant Cell       Date:  2001-10       Impact factor: 11.277

2.  Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity.

Authors:  E A Wills; I S Roberts; M Del Poeta; J Rivera; A Casadevall; G M Cox; J R Perfect
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

3.  A new dominant selectable marker for use in Cryptococcus neoformans.

Authors:  H C McDade; G M Cox
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

Review 4.  A genetic approach to Mammalian glycan function.

Authors:  John B Lowe; Jamey D Marth
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

5.  Molecular and phenotypic analysis of CaVRG4, encoding an essential Golgi apparatus GDP-mannose transporter.

Authors:  Akiko Nishikawa; Jay B Poster; Yoshifumi Jigami; Neta Dean
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

6.  Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: structural differences between encapsulated and acapsular yeast forms.

Authors:  Norton Heise; Ana L S Gutierrez; Katherine A Mattos; Christopher Jones; Robin Wait; José O Previato; Lucia Mendonça-Previato
Journal:  Glycobiology       Date:  2002-07       Impact factor: 4.313

Review 7.  Transmembrane movement of dolichol linked carbohydrates during N-glycoprotein biosynthesis in the endoplasmic reticulum.

Authors:  Jonne Helenius; Markus Aebi
Journal:  Semin Cell Dev Biol       Date:  2002-06       Impact factor: 7.727

8.  Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates.

Authors:  Kirsten Nielsen; Gary M Cox; Ping Wang; Dena L Toffaletti; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum.

Authors:  Hein Sprong; Sophie Degroote; Tommy Nilsson; Masao Kawakita; Nobuhiro Ishida; Peter van der Sluijs; Gerrit van Meer
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

10.  Identification of a Candida glabrata homologue of the S. cerevisiae VRG4 gene, encoding the Golgi GDP-mannose transporter.

Authors:  Akiko Nishikawa; Barbara Mendez; Yoshifumi Jigami; Neta Dean
Journal:  Yeast       Date:  2002-06-15       Impact factor: 3.239

View more
  14 in total

Review 1.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

2.  Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.

Authors:  Sanjoy Paul; Tamara L Doering; W Scott Moye-Rowley
Journal:  Fungal Genet Biol       Date:  2014-11-01       Impact factor: 3.495

3.  Cryptococcus neoformans in Association with Dermatophagoides pteronyssinus has Pro- (IL-6/STAT3 Overproduction) and Anti-inflammatory (CCL2/ERK1/2 Downregulation) Effects on Human Bronchial Epithelial Cells.

Authors:  Henrique Ismarsi Souza; Aline Beatriz Mahler Pereira; Jhony Robison Oliveira; Paulo Roberto Silva; David Nascimento Silva Teixeira; Mario Leon Silva-Vergara; Alexandre Paula Rogério
Journal:  Inflammation       Date:  2022-01-11       Impact factor: 4.092

4.  Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter.

Authors:  Lucy X Li; Angel Ashikov; Hong Liu; Cara L Griffith; Hans Bakker; Tamara L Doering
Journal:  Glycobiology       Date:  2016-08-03       Impact factor: 4.313

Review 5.  Unraveling synthesis of the cryptococcal cell wall and capsule.

Authors:  Zhuo A Wang; Lucy X Li; Tamara L Doering
Journal:  Glycobiology       Date:  2018-10-01       Impact factor: 4.313

6.  Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation.

Authors:  Ezekiel J Maier; Brian C Haynes; Stacey R Gish; Zhuo A Wang; Michael L Skowyra; Alyssa L Marulli; Tamara L Doering; Michael R Brent
Journal:  Genome Res       Date:  2015-02-02       Impact factor: 9.043

7.  Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans.

Authors:  Samantha D M Arras; Sheena M H Chua; Maha S I Wizrah; Joshua A Faint; Amy S Yap; James A Fraser
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

8.  Biology and function of exo-polysaccharides from human fungal pathogens.

Authors:  Krystal Y Chung; Jessica C S Brown
Journal:  Curr Clin Microbiol Rep       Date:  2020-01-17

9.  Xylose donor transport is critical for fungal virulence.

Authors:  Lucy X Li; Carsten Rautengarten; Joshua L Heazlewood; Tamara L Doering
Journal:  PLoS Pathog       Date:  2018-01-18       Impact factor: 6.823

Review 10.  Nutritional Requirements and Their Importance for Virulence of Pathogenic Cryptococcus Species.

Authors:  Rhys A Watkins; Jason S King; Simon A Johnston
Journal:  Microorganisms       Date:  2017-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.